Search Results - TILY, Hajra

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

    Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial by Lai, Zhi-Wei, Kelly, Ryan, Winans, Thomas, Marchena, Ivan, Shadakshari, Ashwini, Yu, Julie, Dawood, Maha, Garcia, Ricardo, Tily, Hajra, Francis, Lisa, Faraone, Stephen V, Phillips, Paul E, Perl, Andras

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    1203 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE

    1203 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in... by Lai, Zhi-Wei, Kelly, Ryan, Winans, Thomas, Marchena, Ivan, Shadakshari, Ashwini, Yu, Julie, Dawood, Maha, Garcia, Ricardo, Tily, Hajra, Francis, Lisa, Faraone, Stephen V, Phillips, Paul E, Perl, Andras

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus

    Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus by RHEW, Elisa Y, LEE, Chin, EKSARKO, Polikseni, DYER, Alan R, TILY, Hajra, SPIES, Stewart, POPE, Richard M, RAMSEY-GOLDMAN, Rosalind

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial

    N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-contr... by Lai, Zhi-Wei, Hanczko, Robert, Bonilla, Eduardo, Caza, Tiffany N., Clair, Brandon, Bartos, Adam, Miklossy, Gabriella, Jimah, John, Doherty, Edward, Tily, Hajra, Francis, Lisa, Garcia, Ricardo, Dawood, Maha, Yu, Jianghong, Ramos, Irene, Coman, Ioana, Faraone, Stephen V., Phillips, Paul E., Perl, Andras

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus

    Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus by Lai, Zhi-Wei, Borsuk, Rebecca, Shadakshari, Ashwini, Yu, Jianghong, Dawood, Maha, Garcia, Ricardo, Francis, Lisa, Tily, Hajra, Bartos, Adam, Faraone, Stephen V, Phillips, Paul, Perl, Andras

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    MTOR ACTIVATION TRIGGERS IL-4 PRODUCTION AND NECROTIC DEATH OF DOUBLE-NEGATIVE T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYHTHEMATOSUS

    MTOR ACTIVATION TRIGGERS IL-4 PRODUCTION AND NECROTIC DEATH OF DOUBLE-NEGATIVE T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYHTHEMATOSUS by Lai, Zhi-Wei, Borsuk, Rebecca, Shadakshari, Ashwini, Yu, Jianghong, Dawood, Maha, Garcia, Ricardo, Francis, Lisa, Tily, Hajra, Bartos, Adam, Faraone, Stephen V., Phillips, Paul, Perl, Andras

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus

    mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients wit... by Lai, Zhi-Wei, Borsuk, Rebecca, Shadakshari, Ashwini, Yu, Jianghong, Dawood, Maha, Garcia, Ricardo, Francis, Lisa, Tily, Hajra, Bartos, Adam, Faraone, Stephen V, Phillips, Paul, Perl, Andras

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Expansion of CD3+/CD4+/CD25+/Foxp3+ T cells in rapamycin-treated lupus patients (143.52)

    Expansion of CD3+/CD4+/CD25+/Foxp3+ T cells in rapamycin-treated lupus patients (143.52) by Perl, Andras, Lai, Zhi-Wei, Telarico, Tiffany, Bartos, Adam, Miklossy, Gabriella, Hanczko, Robert, Francis, Lisa, Tily, Hajra, Ramos, Irene, Garcia, Ricardo, Phillips, Paul, Jimah, John, Doherty, Edward

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors – case report and review of literature

    Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors – case report and review of literature by Tily, Hajra Ismail, Perl, Andras

    Published in BMJ case reports
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    N-ACETYLCYSTEINE REDUCES DISEASE ACTIVITY BY BLOCKING MTOR IN T CELLS OF LUPUS PATIENTS

    N-ACETYLCYSTEINE REDUCES DISEASE ACTIVITY BY BLOCKING MTOR IN T CELLS OF LUPUS PATIENTS by Lai, Zhi-Wei, Hanczko, Robert, Bonilla, Eduardo, Caza, Tiffany N., Clair, Brandon, Bartos, Adam, Miklossy, Gabriella, Jimah, John, Doherty, Edward, Tily, Hajra, Francis, Lisa, Garcia, Ricardo, Dawood, Maha, Yu, Jianghong, Ramos, Irene, Coman, Ioana, Faraone, Stephen V., Phillips, Paul E., Perl, Andras

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: